Clinical trials
Phase 3 Hypersensitivity trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aimmune Therapeutics, Inc. | 3 |
| Allergy Therapeutics | 2 |
| AstraZeneca | 2 |
| Celgene | 2 |
| DBV Technologies | 2 |
| Pfizer | 2 |
| ALK-Abelló A/S | 1 |
| Ellodi Pharmaceuticals, LP | 1 |
| JDP Therapeutics, Inc. | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypersensitivity | 17 |
| Hypersensitivity, Immediate | 7 |
| Immune System Diseases | 5 |
| Peanut Hypersensitivity | 5 |
| Dermatitis, Atopic | 3 |
| Eczema | 3 |
| Eosinophilia | 3 |
| Eosinophilic Esophagitis | 3 |
| Esophageal Diseases | 3 |
| Esophagitis | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.